Reneuron Share Discussion Threads

[algernon2] 19/6/2018 12:40

Afternoon philh75 welcome to the world of Oxb and Reneuron.
JD when he made his comment might have simply been trying to reassure me that RENE was an interesting company with lots going on and was unnappreciated by many.
He might also have been trying to avoid saying that the drop (post consolidation)was unikely to echo that of Rene as he knew the Axovant deal was going to be announced imminently to add a fillip to the Oxb share price.This was well planned on their part.
I did not get the chance to question him further as he was whisked away to answer another PI's question possibly Prams on somethone elses nearby.
So there it is, just a comment made in the heat or cold of the moment.
Good news for Rene could come at any moment but may not for some while.
It is in my mind definitely worth a punt but only your good self can decide if you want to go "all in" or just top up in a cautious wise fashion.
Another one to consider is Summit therapeutics (SUMM) good products and good board.Also spun out of Oxforx University.I wanted to go to their AGM also a few weeks ago but couldn't make that one,coming so soon after the OXB AGM.
Look forward to your posts on OXB and RENE.
May see you at next RENE AGM as I have decided I quite like going to the odd AGM as it livens up the Day nicely.

[philh75] 18/6/2018 15:22

Hi Algernon2,

I was just interested in the comment from JD of OXB in your post 5501.

Can you remember anything else that was said? I'm in both OXB and RENE, and after the stellar rise of OXB this last couple of weeks, I'm interested to figure out whether I should double down on RENE. JD is no fool and he didn't have to say anything there.

Any further comment to the context would be really appreciated.

Phil

[supernumerary] 05/6/2018 23:45

Pity - like all AIM shares, the price is news driven. And of course the anticipation of news...

[algernon2] 05/6/2018 23:02

Nothing imminent supernumerary unless it comes at us out of left field to use a baseball expression.

[supernumerary] 05/6/2018 20:11

algy,

since you ask, 'brassic' should be: boracic = boracic lint = skint

Any expected upcoming events here?

[waterloo01] 05/6/2018 19:07

Not been in this for sometime but did listen into some of the capital markets event, mainly the Q&A and worth a listen. Not sure I personally got much from it that would 'excite'. Scientists running the company.

[algernon2] 05/6/2018 18:46

Apropos of nothing really: I was at the Oxford Biomedica AGM and GM last week and I asked one of the major board members (as OXB were doing a 50 to 1 consolidation)if it would go the way of Reneuron after the consolidation and said I hoped not.
JD then said words to the effect of "..there's a lot more going on in the background with Reneuron than most people realise".
He was then whisked away by another shareholder before I could broaden or narrow the discussion.
I took it to mean good things rather than a veiled warning; but hey what do we know.
Anyway still in and convinced something may (must) happen at some point which will make us and the market sit up and take notice.
I intend to top up a little tomorrow.Not a lot as I am at the moment mostly brassic.
Anyone else got any news or ideas or thoughts?
Maybe even just a poem?

[ashtree2] 17/5/2018 12:16

Rotors..took it off the LSE board director buys and sells.When a director exercises options ,it shows they were sold following exercising.I think.cheers

[dennisbergkamp] 17/5/2018 11:12

Here's hoping its not good money after bad... They do seem to have some great assets here, but maybe their PR should be working better.

D

[ashtree2] 16/5/2018 10:13

17th feb2016..Hunt exercised options of 5,361,673 shares at 1p and sold the bulk of them for around 3p so did very well thank you.He is holding just over 2million from Jan this year..So today one can buy at 0.6p rather surprised that directors arnt piling in.Please correct me if I am wrong.

[rotors] 16/5/2018 10:01

ashtree2, not sure the figures prove that theory.

CFO had a flurry of options exercised, some sold, in Feb 2016 - but a net purchase.
And then a further buy in Feb 2017.

Where did you get your data?

Regards.

[ashtree2] 16/5/2018 09:21

share price has been decimated by director selling otherwise can see no reason for this low price.only just recently seen this one and have taken a nibble.

[small crow] 15/5/2018 08:22

Irrelevant. I'm now down to the last guinea pig in the petting zoo.

[algernon2] 14/5/2018 21:59

Was that your last Goat or last Groat? slight difference in value there S.C.

[small crow] 14/5/2018 09:12

I lost my farm on the stock market years ago. I'm now betting my last goat.

[masingi] 14/5/2018 08:56

Just don't bet the farm.

[masingi] 14/5/2018 08:55

New Tech /Small Crow

Yes indeed, the fundamentals are sound and the science has potential. Time to hold your nerve and sort the men from the boys.

[small crow] 04/5/2018 10:24

Yes, and not the only biotech/pharma in the field - some much bigger cos are investing in exosomes so it will be a race. I suspect RENE will at least be among the front runner, more than that its impossible to judge. So, yes, I would say definitely worth a punt - best case scenario, pennies turn into pounds!

[new tech] 04/5/2018 08:13

RENE - Exosome treatment:

19 minutes 30 sec in there is a slide showing the Exosome treatment tested preclinical in cancer tumours.



The graph shows the average results of 5 in vitro studies. After 18 - 21 days the tumours completely collapsed. The photos show the same repeated in vivo (with animals) again resulting in tumour collapse. It basically programs the cancer cells "to die".

- 12 minutes onwards MH says the new Exosome treatment causes cancer tumour "collapse" after 18 days, leaving just "cellular debris". It seems to be "programming cancer cells to adopt a normal cycle of cell death."



This could be a major breakthrough.

Clinical trial about to start next year in potential breakthrough treatment and shares at an all time low, makes Rene an obvious BUY opportunity.

[ps0u3165] 03/5/2018 08:04

nsk1

2007, 0.40p

Today, 0.0063p

[nsk1] 02/5/2018 18:46

What's it now, if you consider consolidation for LTH's...£0.065

[bigspuds] 02/5/2018 09:00

Yes the science looks Good, but to be honest who would ever know if it was all smoke and mirrors. We all want to be in the next Yahoo, that's why we're here. It's a punt pure and simple.Tin hat's on and hope for the best........tallyho!!